Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ADMA Biologics, Inc.
ADMA Biologics Announces Partial Paydown of Revolving Credit Facility
August 14, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024
August 01, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
May 02, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
March 11, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
March 05, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces CFO Transition
February 28, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 28, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 21, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
February 21, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
January 08, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
December 18, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older
December 12, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
November 16, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
November 08, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
November 01, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
August 09, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
August 02, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
July 19, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
May 03, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Amendment to Credit Agreement
May 02, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 23, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
March 16, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
February 08, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
January 17, 2023
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
December 13, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 09, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
December 07, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Tickers
ADMA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.